The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations

International Journal of Drug Policy

Volumn 32, Issue , 2016, Pages 77-84

  Soussan, Christophe ^a   Kjellgren, Anette ^a  

^a KARLSTAD UNIVERSITY   (Sweden)

Author keywords

Drugs; Internet; Legal highs; Motivation; Novel Psychoactive Substances

Indexed keywords

CANNABINOID; GABAERGIC RECEPTOR AFFECTING AGENT; OPIATE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; ATTITUDE; COPING BEHAVIOR; DRUG USE; EXPLORATORY BEHAVIOR; FEMALE; HARM REDUCTION; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; LEGAL ASPECT; MALE; MEDICAL HISTORY; MOTIVATION; OPIATE ADDICTION; PLEASURE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; PSYCHOLOGICAL WELLBEING ASSESSMENT; RELIGION; SELF EVALUATION; WORLD HEALTH ORGANIZATION 5 WELLBEING INDEX; ADDICTION; ADOLESCENT; DRUG DEPENDENCE; INTERNET; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATTITUDE; BEHAVIOR, ADDICTIVE; FEMALE; HALLUCINOGENS; HARM REDUCTION; HUMANS; INTERNET; MALE; MIDDLE AGED; MOTIVATION; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84967106590     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2016.03.007     Document Type: Article

References (28)

1. Adams, J.B., Heat, A.J., Young, S.E., Hewitt, J.K., Corley, R.P., Stallings, M.C., Relationships between personality and preferred substance and motivations for use among adolescent substance abusers. The American Journal of Drug and Alcohol Abuse 29 (2003), 691–712, 10.1081/ADA-120023465.
2. Barratt, M.J., Cakic, V., Lenton, S., Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review 32 (2013), 141–146, 10.1111/j.1465-3362.2012.00519.x.
3. Boys, A., Marsden, J., Strang, J., Understanding reasons for drug use amongst young people: A functional perspective. Health Education Research 16 (2001), 457–469, 10.1093/her/16.4.457.
4. Corazza, O., Demetrovics, Z., van den Brink, W., Schifano, F., ‘Legal highs’ an inappropriate term for ‘Novel Psychoactive Drugs’ in drug prevention and scientific debate. International Journal of Drug Policy 24 (2013), 82–83, 10.1016/j.drugpo.2012.06.005.
5. Corazza, O., Simonato, P., Corkery, J., Trincas, G., Shifano, F., ”Legal highs”: Safe and legal “heavens”? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Rivista di Psichiatria 49 (2014), 89–94, 10.1708/1461.16147.
6. Davey, Z., Schifano, F., Corazza, O., Deluca, P., e-Psychonauts: Conducting research in online drug forum communities. Journal of Mental Health 21 (2012), 386–394.
7. Eurobarometer 401, Young people and drugs. 2014 http://ec.europa.eu/public_opinion/flash/fl_401_en.pdf Accessed 21.09.15.
8. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), New psychoactive substances in Europe. 2015 http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances Accessed 12.09.15.
9. Gibbons, S., ‘Legal highs’ – Novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clinical Toxicology 50 (2012), 15–24, 10.3109/15563650.2011.645952.
10. Johnson, L.A., Johnson, R.L., Portier, R., Current “legal highs”. The Journal of Emergency Medicine 44 (2013), 1108–1115, 10.1016/j.jemermed.2012.09.147.
11. Kjellgren, A., Soussan, C., Heaven and hell – A phenomenological study of recreational use of 4 HO-MET in Sweden. Journal of Psychoactive Drugs 43 (2011), 211–219, 10.1080/02791072.20l1.605699.
12. McElrath, K., O'Neill, C., Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply. International Journal of Drug Policy 22 (2011), 120–127, 10.1016/j.drugpo.2010.11.001.
13. Measham, F., Moore, K., Newcombe, R., Welch, Z., Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today 10 (2010), 14–21, 10.5042/daat.2010.0123.
14. Moore, K., Dargan, P.I., Wood, D.M., Measham, F., Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between Mephedrone, Ecstasy and Cocaine. European Addiction Research 19 (2013), 276–282, 10.1159/000346678.
15. Nicholson, T., Duncan, D.F., White, J.B., Is recreational drug use normal?. Journal of Substance Use 7 (2002), 116–123, 10.1080/14659890209169340.
16. Novacek, J., Raskin, R., Hogan, R., Why do adolescents use drugs? Age, sex, and user differences. Journal of Youth and Adolescence 20 (1991), 475–492, 10.1007/BF01540632.
17. Sande, M., Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users. International Journal of Drug Policy 27 (2016), 65–73, 10.1016/j.drugpo.2015.03.005.
18. Soussan, C., Kjellgren, A., The flip side of “spice”: The adverse effects of synthetic cannabinoids as discussed on a Swedish Internet forum. Nordic Studies on Alcohol and Drugs 31 (2013), 1–13, 10.2478/nsad-2014-0016.
19. Soussan, C., Kjellgren, A., Harm reduction and knowledge exchange – A qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal, 11, 2014, 10.1186/1477-7517-11-25.
20. Soussan, C., Kjellgren, A., ”Chasing the high” – Experiences of ethylphenidate as described on international internet forums. Substance Abuse: Research and Treatment 9 (2015), 9–16, 10.4137/SART.S22495.
21. Topp, C.W., Østergaard, S.D., Søndergaard, S., The WHO-5 well-being index: A systematic review of the literature. Psychotherapy and Psychosomatics 84 (2015), 167–176, 10.1159/000376585.
22. Vardakou, I., Pistos, C., Spiliopoulou, Ch., Drugs for youth via Internet and the example of mephedrone. Toxicology Letters 201 (2010), 191–195, 10.1016/j.toxlet.2010.l2.014.
23. Werse, B., Morgenstern, C., How to handle legal highs? Findings from a German online survey and considerations on drug policy issues. Drug and Alcohol Today 12 (2012), 222–231, 10.1108/17459261211286636.
24. Winstock, A.R., Barratt, M.J., Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence 131 (2013), 106–111, 10.1016/j.drugalcdep.2012.12.011.
25. Winstock, A.R., Lawn, W., Deluca, P., Borschmann, R., Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample. Drug and Alcohol Review, 2015, 10.1111/dar.12259.
26. World Health Organization (WHO), Global status report on alcohol and health – 2014. 2014 http://www.who.int/substance_abuse/publications/global_alcohol_report Accessed 19.09.15.
27. Wood, D.M., Dargan, P.I., Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. Journal of Medical Toxicology 8 (2012), 300–303, 10.1007/s13181-012-0241-3.
28. Wood, D.M., Hunter, L., Measham, F., Dargan, P.I., Limited use of novel psychoactive substances in South London nightclubs. QJM 105 (2012), 959–964, 10.1093/qjmed/hcs107.